-
2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one hydrate
-
ChemBase ID:
72594
-
Molecular Formular:
C12H17N5O4
-
Molecular Mass:
295.29448
-
Monoisotopic Mass:
295.12805405
-
SMILES and InChIs
SMILES:
n1c([nH]c2c(c1=O)ncn2C1C[C@@H]([C@H](C1=C)CO)O)N.O
Canonical SMILES:
OC[C@@H]1[C@@H](O)CC(C1=C)n1cnc2c1[nH]c(N)nc2=O.O
InChI:
InChI=1S/C12H15N5O3.H2O/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20;/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20);1H2/t6-,7?,8-;/m0./s1
InChIKey:
YXPVEXCTPGULBZ-JBDQBEHPSA-N
-
Cite this record
CBID:72594 http://www.chembase.cn/molecule-72594.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one hydrate
|
|
|
IUPAC Traditional name
|
2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one hydrate
|
|
|
Synonyms
|
Baraclude
|
Entecavir hydrate
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
8.0033045
|
H Acceptors
|
7
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-1.4469311
|
LogD (pH = 7.4)
|
-1.5362015
|
Log P
|
-1.4446591
|
Molar Refractivity
|
71.0008 cm3
|
Polarizability
|
26.432161 Å3
|
Polar Surface Area
|
125.76 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
Storage Condition
|
-20°C
|
Show
data source
|
|
Salt Data
|
hydrate
|
Show
data source
|
|
DETAILS
DETAILS
Selleck Chemicals
Selleck Chemicals -
S1252
|
Research Area: Hepatitis B Biological Activity: Entecavir hydrate is an oral antiviral drug used in the treatment of hepatitis B infection. Entecavir hydrate is a nucleoside analog (more specifically, a guanine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. Entecavir hydrate is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). Entecavir hydrate is also indicated for the treatment of chronic hepatitis B in adults with HIV/AIDS infection. However, Entecavir hydrate is not active against HIV. [1] |
PATENTS
PATENTS
PubChem Patent
Google Patent